{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:22:10Z","timestamp":1791566530336,"version":"4.3.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8200172881973540"],"award-info":[{"award-number":["8200172881973540"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Interdisciplinary Project of West China Hospital"},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYGD18015"],"award-info":[{"award-number":["ZYGD18015"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYJC18003"],"award-info":[{"award-number":["ZYJC18003"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYJC18024"],"award-info":[{"award-number":["ZYJC18024"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["20YYJC3358"],"award-info":[{"award-number":["20YYJC3358"]}]},{"name":"Innovative Research Program of Sichuan University","award":["2022SCUH0020"],"award-info":[{"award-number":["2022SCUH0020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Anti-melanoma differentiation-associated gene 5 antibody-positive (anti-MDA5+) DM complicated by rapidly progressive interstitial lung disease (RP-ILD) has a high incidence and poor prognosis. The objective of this study was to establish a model for the prediction and early diagnosis of anti-MDA5+ DM-associated RP-ILD based on clinical manifestations and imaging features.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 103 patients with anti-MDA5+ DM were included. The patients were randomly split into training and testing sets of 72 and 31 patients, respectively. After image analysis, we collected clinical, imaging and radiomics features from each patient. Feature selection was performed first with the minimum redundancy and maximum relevance algorithm and then with the best subset selection method. The final remaining features comprised the radscore. A clinical model and imaging model were then constructed with the selected independent risk factors for the prediction of non-RP-ILD and RP-ILD. We also combined these models in different ways and compared their predictive abilities. A nomogram was also established. The predictive performances of the models were assessed based on receiver operating characteristics curves, calibration curves, discriminability and clinical utility.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The analyses showed that two clinical factors, dyspnoea (P\u2009=\u20090.000) and duration of illness in months (P\u2009=\u20090.001), and three radiomics features (P\u2009=\u20090.001, 0.044 and 0.008, separately) were independent predictors of non-RP-ILD and RP-ILD. However, no imaging features were significantly different between the two groups. The radiomics model built with the three radiomics features performed worse than the clinical model and showed areas under the curve (AUCs) of 0.805 and 0.754 in the training and test sets, respectively. The clinical model demonstrated a good predictive ability for RP-ILD in MDA5+ DM patients, with an AUC, sensitivity, specificity and accuracy of 0.954, 0.931, 0.837 and 0.847 in the training set and 0.890, 0.875, 0.800 and 0.774 in the testing set, respectively. The combination model built with clinical and radiomics features performed slightly better than the clinical model, with an AUC, sensitivity, specificity and accuracy of 0.994, 0.966, 0.977 and 0.931 in the training set and 0.890, 0.812, 1.000 and 0.839 in the testing set, respectively. The calibration curve and decision curve analyses showed satisfactory consistency and clinical utility of the nomogram.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our results suggest that the combination model built with clinical and radiomics features could reliably predict the occurrence of RP-ILD in MDA5+ DM patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead263","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T20:58:28Z","timestamp":1685653108000},"page":"809-816","source":"Crossref","is-referenced-by-count":17,"title":["A nomogram based on clinical factors and CT radiomics for predicting anti-MDA5+ DM complicated by RP-ILD"],"prefix":"10.1093","volume":"63","author":[{"given":"Yanhong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital, Sichuan University , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Chengdu First People\u2019s Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-1579","authenticated-orcid":false,"given":"Yubin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-2352","authenticated-orcid":false,"given":"Tong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Shanghai United Imaging Intelligence , Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital, Sichuan University , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Rare Diseases Center, West China Hospital, Sichuan University , Chengdu, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital , Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"2024030205485413700_kead263-B1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","article-title":"Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study","volume":"147","author":"Hamaguchi","year":"2011","journal-title":"Arch Dermatol"},{"key":"2024030205485413700_kead263-B2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial lung disease in anti-MDA5 positive dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024030205485413700_kead263-B3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1684\/ejd.2019.3634","article-title":"Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease","volume":"29","author":"Motegi","year":"2019","journal-title":"Eur J Dermatol"},{"key":"2024030205485413700_kead263-B4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/rheumatology\/keu385","article-title":"Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis","volume":"54","author":"Kobayashi","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2024030205485413700_kead263-B5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","article-title":"Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study","volume":"8","author":"Vuillard","year":"2018","journal-title":"Ann Intensive Care"},{"key":"2024030205485413700_kead263-B6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3899\/jrheum.160682","article-title":"Antimelanoma differentiation-associated gene 5 antibody: expanding the clinical spectrum in North American patients with dermatomyositis","volume":"44","author":"Moghadam-Kia","year":"2017","journal-title":"J Rheumatol"},{"key":"2024030205485413700_kead263-B7","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2024030205485413700_kead263-B8","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","article-title":"Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review","volume":"39","author":"Huang","year":"2019","journal-title":"Rheumatol Int"},{"key":"2024030205485413700_kead263-B9","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2024030205485413700_kead263-B10","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/kez185","article-title":"Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD","volume":"58","author":"Horiike","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2024030205485413700_kead263-B11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti-MDA5 antibody-positive dermatomyositis patients: implications for rapidly progressive interstitial lung disease prediction","volume":"75","author":"Xu","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024030205485413700_kead263-B12","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1038\/s41598-021-96292-w","article-title":"A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis","volume":"11","author":"Xu","year":"2021","journal-title":"Sci Rep"},{"key":"2024030205485413700_kead263-B13","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1007\/s10067-019-04673-4","article-title":"A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis","volume":"38","author":"Li","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2024030205485413700_kead263-B14","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","article-title":"Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use","volume":"34","author":"Kerr","year":"2016","journal-title":"J Clin Oncol"},{"key":"2024030205485413700_kead263-B15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir Med"},{"key":"2024030205485413700_kead263-B16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/diagnostics12041002","article-title":"Radiomics for the prediction of response to antifibrotic treatment in patients with idiopathic pulmonary fibrosis: a pilot study","volume":"12","author":"Yang","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2024030205485413700_kead263-B17","doi-asserted-by":"crossref","first-page":"915243","DOI":"10.3389\/fmed.2022.915243","article-title":"Diagnosis of idiopathic pulmonary fibrosis in high-resolution computed tomography scans using a combination of handcrafted radiomics and deep learning","volume":"9","author":"Refaee","year":"2022","journal-title":"Front Med"},{"key":"2024030205485413700_kead263-B18","doi-asserted-by":"crossref","first-page":"768052","DOI":"10.3389\/fmed.2021.768052","article-title":"A computed tomography radiomics-based prediction model on interstitial lung disease in anti-MDA5-positive dermatomyositis","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med"},{"key":"2024030205485413700_kead263-B19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2024030205485413700_kead263-B20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2024030205485413700_kead263-B21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/rheumatology\/keac450","article-title":"Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China","volume":"62","author":"You","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2024030205485413700_kead263-B22","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/mp.14609","article-title":"Abnormal lung quantification in chest CT images of COVID-19 patients with deep learning and its application to severity prediction","volume":"48","author":"Shan","year":"2021","journal-title":"Med Phys"},{"key":"2024030205485413700_kead263-B23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jrid.2020.04.004","article-title":"Quantitative computed tomography of the coronavirus disease 2019 (COVID-19) pneumonia","volume":"7","author":"Cheng","year":"2020","journal-title":"Radiol Infect Dis"},{"key":"2024030205485413700_kead263-B24","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1109\/TMI.2020.2995508","article-title":"Dual-sampling attention network for diagnosis of COVID-19 from community acquired pneumonia","volume":"39","author":"Ouyang","year":"2020","journal-title":"IEEE Trans Med Imaging"},{"key":"2024030205485413700_kead263-B25","doi-asserted-by":"crossref","first-page":"065031","DOI":"10.1088\/1361-6560\/abe838","article-title":"Large-scale screening of COVID-19 from community acquired pneumonia using infection size-aware classification","volume":"66","author":"Shi","year":"2021","journal-title":"Phys Med Biol"},{"key":"2024030205485413700_kead263-B26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"2024030205485413700_kead263-B27","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3390\/s21051846","article-title":"Maximum relevance minimum redundancy dropout with informative kernel determinantal point process","volume":"21","author":"Saffari","year":"2021","journal-title":"Sensors (Basel)"},{"key":"2024030205485413700_kead263-B28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","article-title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","volume":"80","author":"Spagnolo","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2024030205485413700_kead263-B29","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.12788\/cutis.0260","article-title":"Ulcerative heliotrope rash in antimelanoma differentiation-associated gene 5 dermatomyositis","volume":"107","author":"Daugherty","year":"2021","journal-title":"Cutis"},{"key":"2024030205485413700_kead263-B30","doi-asserted-by":"crossref","first-page":"845988","DOI":"10.3389\/fimmu.2022.845988","article-title":"Different multivariable risk factors for rapid progressive interstitial lung disease in anti-MDA5 positive dermatomyositis and anti-synthetase syndrome","volume":"13","author":"Zuo","year":"2022","journal-title":"Front Immunol"},{"key":"2024030205485413700_kead263-B31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/joim.13154","article-title":"IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis\/dermatomyositis","volume":"289","author":"Shimizu","year":"2021","journal-title":"J Intern Med"},{"key":"2024030205485413700_kead263-B32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","article-title":"Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis","volume":"35","author":"Xu","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2024030205485413700_kead263-B33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.41566","article-title":"Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"73","author":"Gono","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2024030205485413700_kead263-B34","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","article-title":"Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2024030205485413700_kead263-B35","doi-asserted-by":"crossref","first-page":"e89610","DOI":"10.1371\/journal.pone.0089610","article-title":"Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute\/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a\/glucocorticosteroid combination therapy: a case control study [corrected]","volume":"9","author":"Isoda","year":"2014","journal-title":"PLoS One"},{"key":"2024030205485413700_kead263-B36","doi-asserted-by":"crossref","first-page":"733599","DOI":"10.3389\/fmed.2021.733599","article-title":"A clinical risk model to predict rapidly progressive interstitial lung disease incidence in dermatomyositis","volume":"8","author":"Li","year":"2021","journal-title":"Front Med"},{"key":"2024030205485413700_kead263-B37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10067-015-2866-5","article-title":"HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients","volume":"34","author":"Zou","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2024030205485413700_kead263-B38","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","article-title":"Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model","volume":"158","author":"Lian","year":"2020","journal-title":"Chest"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead263\/50682286\/kead263.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/3\/809\/56818634\/kead263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/3\/809\/56818634\/kead263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T05:49:20Z","timestamp":1709358560000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/3\/809\/7189751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6,2]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead263","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,6,2]]}}}